[{"bioset_name":"SBRI_AA_VN6+2_020_12hr","treatment_amount":"1.00E+05 PFU","treatment_type":"Infectious Agent","strain":"Not Applicable","bioset_id":"1250","exp_id":"170","exp_type":"Transcript Quantification","treatment_duration":"12","study_title":"SBRI_AA:  PR8, X31, VN6+2 12hrs infection in whole lung tissue.","exp_title":"SBRI_AA_E1","study_name":"SBRI_AA","organism":"Mus musculus","bioset_criteria":"Bioset = -1.5  > |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that lists genes that are differentially expressed in infected cells compared to mock samples","bioset_type":"MS-Proteomics Differential Abundance","entity_count":"88","treatment_name":"VN1203(6+2)_RG (H5N1) | Mock Infection","exp_name":"SBRI_AA_E1","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284004987273200},{"treatment_duration":"96","exp_type":"Transcript Quantification","exp_id":"139","bioset_id":"920","strain":"HAE cell","treatment_type":"Infectious Agent","treatment_amount":"2.00E+00 MOI","bioset_name":"SHAE004_SARS_96h_array","treatment_name":"icSARS CoV Urbani | Mock Infection","exp_name":"SHAE004-R","entity_count":"1","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from HAE cells infected with wild type SARS, SARS BatSRBD, SARS deltaORF6 mutants, A/CA/04/2009 (H1N1) or time-matched mock infections.  The time points are 0, 12, 24, 36, 48, 60, 72, 84 and 96h post-infection for SARS viruses (except SHAE003 which did not include the 12 and 36h timepoints), 0, 6, 12, 18, 24, 36 and 48h post-infection for H1N1 and 0, 6, 12, 18, 24, 36, 48, 60, 72, 84 and 96h for mocks.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","bioset_type":"Microarray Differential Expression","organism":"Homo sapiens","study_name":"SHAE005","exp_title":"SHAE004-R","study_title":"SHAE005: SARS-CoV, deltaORF6, BatSRBD mutants and A/CA/04/2009 (H1N1) infection of HAE cells: A time course","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005020827600},{"study_name":"FLX0004","organism":"Homo sapiens","bioset_description":"Differential expression analysis (RNA-Seq) of MDM cells infected with influenza A/Vietnam/1203/04 (HALo) for 18 hours, compared to time-matched mock-infected samples.","bioset_criteria":"|FC| > 2, q  0.05","bioset_type":"RNA-seq Differential Expression","exp_name":"E_R_MDM_H5N1","treatment_name":"A/Vietnam/1203/04 (H5N1) HALo | A/Vietnam/1203/04 (H5N1) HALo","entity_count":"7253","study_title":"FLX0004: Infection of Human Monocyte-Derived Macrophage Cells with Influenza A Virus","exp_title":"E_R_MDM_H5N1","strain":"MDM cells","bioset_id":"1488","exp_id":"243","exp_type":"Transcript Quantification","treatment_duration":"18","bioset_name":"B_R_MDM_H5N1_18h","treatment_amount":"2 MOI","treatment_type":"Infectious Agent","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005022924800},{"exp_title":"ICL010-R","study_title":"ICL010: A/Netherlands/602/2009 (H1N1) and A/CA/04/2009 (H1N1) infection in Calu3 cells: A time course","bioset_criteria":"Passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_type":"Microarray Differential Expression","bioset_description":"This is a results matrix that lists  genes  that are differentially expressed in infected cells compared to time matched mock samples. Cells were infected with A/Netherlands/602/2009 (H1N1) or A/CA/04/2009 (H1N1).  Time points are 0, 3, 7, 12, 18, 24, 36 and 48hrs post infection for A/Netherlands and 0, 12, 24 and 48hrs for A/CA/04/2009.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","treatment_name":"CA04 (H1N1) | Mock Infection","exp_name":"ICL010-R","study_name":"ICL010","organism":"Homo sapiens","treatment_type":"Infectious Agent","bioset_name":"ICL010_Cal_0h_array_DE","treatment_amount":"3.00E+00 MOI","exp_id":"153","treatment_duration":"0","exp_type":"Transcript Quantification","strain":"Calu-3 cell","bioset_id":"1073","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005025022000},{"treatment_type":"Infectious Agent","treatment_amount":"1.00E+04 PFU","bioset_name":"IM005_VN1203-PB2-627E_7d_proteomics_DE","exp_id":"156","exp_type":"Protein Quantification","treatment_duration":"168","strain":"Not Applicable","bioset_id":"1109","exp_title":"IM005-P","study_title":"IM005: Vietnam/1203-PB2-627E/2004 (H5N1) infection in C57 Black 6 Mice: A time course","bioset_criteria":"Criteria of p-value <0 .05","bioset_type":"MS-Proteomics Differential Abundance","bioset_description":"This is a results matrix that lists proteins  that are differentially expressed in A/Vietnam/1203-CIP048_RG2/2004 (H5N1) infected mice compared to time matched mock samples.  Time points are 1, 2, 4 and 7 days post infection for mutant virus and mock infections.  Differential Expression Criteria: a p-value < .05.","treatment_name":"VN1203-CIP048_RG2  (H5N1) | Mock Infection","exp_name":"IM005-P","entity_count":"847","study_name":"IM005","organism":"Mus musculus","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005026070500},{"strain":"Calu-3 cell","bioset_id":"1045","exp_id":"150","treatment_duration":"30","exp_type":"Transcript Quantification","bioset_name":"ICL006_30hr_H1N1","treatment_amount":"3.00E+00 MOI","treatment_type":"Infectious Agent","study_name":"ICL006","organism":"Homo sapiens","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that lists all DE genes compared to time matched mock samples for Calu-3 cell samples infected with A/CA/04/2009(H1N1) at an MOI of 3.  Time points are 0, 3, 7, 12, 18, 24, 30,36,48 h post infection.  Differential Expression Criteria: passes Agilent QC flag and |FC| > 1.5 and q-value < .05.","bioset_type":"Microarray Differential Expression","treatment_name":"CA04 (H1N1) | Mock Infection","exp_name":"ICL006-R","entity_count":"1326","study_title":"ICL006: A/CA/04/09 (H1N1) infection in Calu3 cell: A time course","exp_title":"ICL006-R","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005027119000},{"bioset_id":"1651","strain":"C57BL/6J","treatment_duration":"48","exp_type":"Transcript Quantification","exp_id":"308","bioset_name":"IM101-R_CA04_WT_2d","treatment_amount":"10000 PFU","treatment_type":"Infectious Agent","organism":"Mus musculus","study_name":"IM101","treatment_name":"A/California/04/09 (H1N1)","exp_name":"IM101-R","entity_count":"330","bioset_type":"Microarray Differential Expression","bioset_criteria":"FC>=1.5 (log2 FC >= 0.58)and q-value <= 0.05","bioset_description":"Differential expression analysis  of  mouse lung tissue infected with wild type H1N1 for 2 days, compared to time-matched mock-infected samples.","study_title":"IM101: Infection of C57BL/6J mouse lung with wild type and mutant H5N1, H1N1 strains","exp_title":"IM101-R","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005028167700},{"study_title":"FLX0003 : Infection of Human Tracheobronchial Epithelial Cells with Influenza A Virus","exp_title":"E_R_HTBE_H3N2","organism":"Homo sapiens","study_name":"FLX0003","treatment_name":"A/Wyoming/03/03 (H3N2) | Vehicle Control","exp_name":"E_R_HTBE_H3N2","entity_count":"2103","bioset_type":"RNA-seq Differential Expression","bioset_criteria":"|FC| > 2, q < 0.05","bioset_description":"Differential expression analysis (RNA-Seq) of HTBE cells infected with influenza A/Wyoming/03/03 for 18 hours, compared to time-matched mock-infected samples.","bioset_name":"B_R_HTBE_H3N2_18h","treatment_amount":"5 MOI","treatment_type":"Infectious Agent","bioset_id":"1470","strain":"HTBE cells","exp_type":"Transcript Quantification","treatment_duration":"18","exp_id":"223","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005029216300},{"treatment_amount":"2.00E+00 MOI","bioset_name":"SHAE002_BAT_96h_array","treatment_type":"Infectious Agent","bioset_id":"842","strain":"HAE cell","treatment_duration":"96","exp_type":"Transcript Quantification","exp_id":"137","study_title":"SHAE005: SARS-CoV, deltaORF6, BatSRBD mutants and A/CA/04/2009 (H1N1) infection of HAE cells: A time course","exp_title":"SHAE002-R","organism":"Homo sapiens","study_name":"SHAE005","treatment_name":"icSARS Bat SRBD | Mock Infection","exp_name":"SHAE002-R","entity_count":"219","bioset_type":"Microarray Differential Expression","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from HAE cells infected with wild type SARS, SARS BatSRBD, SARS deltaORF6 mutants, A/CA/04/2009 (H1N1) or time-matched mock infections.  The time points are 0, 12, 24, 36, 48, 60, 72, 84 and 96h post-infection for SARS viruses (except SHAE003 which did not include the 12 and 36h timepoints), 0, 6, 12, 18, 24, 36 and 48h post-infection for H1N1 and 0, 6, 12, 18, 24, 36, 48, 60, 72, 84 and 96h for mocks.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005030264800},{"exp_title":"WCT001-R","study_title":"WCT001: Infection of C57BL/6J mouse cortex with wild type and mutant west nile virus strains","entity_count":"3886","treatment_name":"West Nile Virus E218A mutant","exp_name":"WCT001-R","bioset_criteria":"FC>=1.5 (log2 FC >= 0.58)and q-value <= 0.05","bioset_description":"Differential expression analysis  of cortex infected with WNV-E218A for 1 day, compared to time-matched mock-infected samples.","bioset_type":"Microarray Differential Expression","organism":"Mus musculus","study_name":"WCT001","treatment_type":"Infectious Agent","bioset_name":"WCT001-R_WNV-E218A_1d","treatment_amount":"100 FFU","exp_type":"Transcript Quantification","treatment_duration":"24","exp_id":"317","bioset_id":"1730","strain":"C57BL/6J","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","genome_id":["10090.24"],"_version_":1809284005032362000},{"exp_title":"SM014-R","study_title":"SM014: SARS nsp16 mutant infection in C57 Black 6 Mice: A time course","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_type":"Microarray Differential Expression","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from mice infected with SARS MA15, SARS nsp16 mutant or time-matched mock infections.  Time points are 1, 2, 4 and 7 days post-infection for mutant virus and mock infections.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","treatment_name":"icSARS dNSP16 | Mock Infection","exp_name":"SM014-R","entity_count":"1","study_name":"SM014","organism":"Mus musculus","treatment_type":"Infectious Agent","bioset_name":"SM014_nsp16_10^5_1d_array","treatment_amount":"1.00E+05 PFU","exp_id":"165","exp_type":"Transcript Quantification","treatment_duration":"24","strain":"Not Applicable","bioset_id":"1193","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005033410600},{"treatment_type":"Infectious Agent","treatment_amount":"2.00E+00 MOI","bioset_name":"SHAE002_SARS_96h_array","exp_id":"137","exp_type":"Transcript Quantification","treatment_duration":"96","strain":"HAE cell","bioset_id":"858","exp_title":"SHAE002-R","study_title":"SHAE005: SARS-CoV, deltaORF6, BatSRBD mutants and A/CA/04/2009 (H1N1) infection of HAE cells: A time course","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_type":"Microarray Differential Expression","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from HAE cells infected with wild type SARS, SARS BatSRBD, SARS deltaORF6 mutants, A/CA/04/2009 (H1N1) or time-matched mock infections.  The time points are 0, 12, 24, 36, 48, 60, 72, 84 and 96h post-infection for SARS viruses (except SHAE003 which did not include the 12 and 36h timepoints), 0, 6, 12, 18, 24, 36 and 48h post-infection for H1N1 and 0, 6, 12, 18, 24, 36, 48, 60, 72, 84 and 96h for mocks.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","treatment_name":"icSARS CoV Urbani | Mock Infection","exp_name":"SHAE002-R","entity_count":"262","study_name":"SHAE005","organism":"Homo sapiens","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005034459100},{"treatment_amount":"2.00E+00 MOI","bioset_name":"SHAE003_H1N1_24h_array","treatment_type":"Infectious Agent","bioset_id":"878","strain":"HAE cell","exp_type":"Transcript Quantification","treatment_duration":"24","exp_id":"138","study_title":"SHAE005: SARS-CoV, deltaORF6, BatSRBD mutants and A/CA/04/2009 (H1N1) infection of HAE cells: A time course","exp_title":"SHAE003-R","organism":"Homo sapiens","study_name":"SHAE005","entity_count":"3253","treatment_name":"CA04 (H1N1) | Mock Infection","exp_name":"SHAE003-R","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from HAE cells infected with wild type SARS, SARS BatSRBD, SARS deltaORF6 mutants, A/CA/04/2009 (H1N1) or time-matched mock infections.  The time points are 0, 12, 24, 36, 48, 60, 72, 84 and 96h post-infection for SARS viruses (except SHAE003 which did not include the 12 and 36h timepoints), 0, 6, 12, 18, 24, 36 and 48h post-infection for H1N1 and 0, 6, 12, 18, 24, 36, 48, 60, 72, 84 and 96h for mocks.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","bioset_type":"Microarray Differential Expression","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005035507700},{"exp_title":"SHAE004-R","study_title":"SHAE005: SARS-CoV, deltaORF6, BatSRBD mutants and A/CA/04/2009 (H1N1) infection of HAE cells: A time course","entity_count":"1","exp_name":"SHAE004-R","treatment_name":"icSARS dORF6 | Mock Infection","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from HAE cells infected with wild type SARS, SARS BatSRBD, SARS deltaORF6 mutants, A/CA/04/2009 (H1N1) or time-matched mock infections.  The time points are 0, 12, 24, 36, 48, 60, 72, 84 and 96h post-infection for SARS viruses (except SHAE003 which did not include the 12 and 36h timepoints), 0, 6, 12, 18, 24, 36 and 48h post-infection for H1N1 and 0, 6, 12, 18, 24, 36, 48, 60, 72, 84 and 96h for mocks.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","bioset_type":"Microarray Differential Expression","organism":"Homo sapiens","study_name":"SHAE005","treatment_type":"Infectious Agent","bioset_name":"SHAE004_dORF6_24h_array","treatment_amount":"2.00E+00 MOI","treatment_duration":"24","exp_type":"Transcript Quantification","exp_id":"139","bioset_id":"923","strain":"HAE cell","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005036556300},{"treatment_type":"Infectious Agent","bioset_name":"SM014_nsp16_10^5_2d_array","treatment_amount":"1.00E+05 PFU","exp_id":"165","exp_type":"Transcript Quantification","treatment_duration":"48","strain":"Not Applicable","bioset_id":"1194","exp_title":"SM014-R","study_title":"SM014: SARS nsp16 mutant infection in C57 Black 6 Mice: A time course","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from mice infected with SARS MA15, SARS nsp16 mutant or time-matched mock infections.  Time points are 1, 2, 4 and 7 days post-infection for mutant virus and mock infections.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_type":"Microarray Differential Expression","entity_count":"2021","treatment_name":"icSARS dNSP16 | Mock Infection","exp_name":"SM014-R","study_name":"SM014","organism":"Mus musculus","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005038653400},{"exp_id":"313","exp_type":"Transcript Quantification","treatment_duration":"0","strain":"HAE cell","bioset_id":"1703","treatment_type":"Infectious Agent","treatment_amount":"5.0E+00 PFU","bioset_name":"MHAE002-R_MERS-CoV_0h","bioset_description":"Differential expression analysis  of Primary airway epithelial cells infected with MERS-CoV for 0 hours, compared to time-matched mock-infected samples.","bioset_criteria":"FC>=1.5 (log2 FC >= 0.58)and q-value <= 0.05","bioset_type":"Microarray Differential Expression","treatment_name":"MHAE002_DD068K_MERS-CoV-WT","exp_name":"MHAE002-R","entity_count":"39","study_name":"MHAE002_R","organism":"Homo sapiens","exp_title":"MHAE002-R","study_title":"MHAE002: Timecourse of an infection of primary human airway epithelial cells with MERS-CoV","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005039702000},{"exp_title":"IM102-R","study_title":"IM102: Infection of C57BL/6J mouse lung tissue with wild type and mutant H7N9 strains","treatment_name":"AH1-NS1-L103F/I106M  (H7N9 mutant)","exp_name":"IM102-R","entity_count":"159","bioset_criteria":"|FC| >=1.5, q0.05","bioset_description":"Differential expression analysis  of  mouse lung tissue infected with AH1-NS1-L103F/I106M for 2 days, compared to time-matched mock-infected samples.","bioset_type":"Microarray Differential Expression","organism":"Mus musculus","study_name":"IM102","treatment_type":"Infectious Agent","bioset_name":"IM102-R_AH1-FM_2d","treatment_amount":"10000 PFU","treatment_duration":"48","exp_type":"Transcript Quantification","exp_id":"309","bioset_id":"1666","strain":"C57BL/6J","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005040750600},{"strain":"Not Applicable","bioset_id":"789","exp_id":"130","exp_type":"Transcript Quantification","treatment_duration":"72","bioset_name":"IM002_Mex_10^6pfu_D3_array","treatment_amount":"1.00E+06 PFU","treatment_type":"Infectious Agent","study_name":"IM002","organism":"Mus musculus","bioset_type":"Microarray Differential Expression","bioset_criteria":"passes Agilent QC flag and |FC| &gt; 1.5 and q-value &lt; .05","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from BALB/c mice infected with A/NJ/8/76 (H1N1), A/Mexico/4482/2009 (H1N1), A/Brisbane/59/2007 (H1N1), reconstructed 1918 (H1N1) or time-matched mock infections. Time points are 1, 3 and 5 days post-infection for mutant virus and mock infections. Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","exp_name":"IM002-R","treatment_name":"Mex/4482/09 (H1N1) | Mock Infection","entity_count":"1421","study_title":"IM002: Influenza A/NJ/8/76 (H1N1), A/Mexico/4482/2009 (H1N1), Brisbane/59/2007 (H1N1) or reconstructed 1918 (H1N1) infection in BALB/c mice: A time course.","exp_title":"IM002-R","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005040750600},{"study_name":"IM007","organism":"Mus musculus","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from mice infected with A/Vietnam/1203-CIP048_RG4/2004 (H5N1) or time-matched mock infections.  Time points are 1, 2, 4 and 7 days post infection for mutant virus and mock infections.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","bioset_type":"Microarray Differential Expression","treatment_name":"VN1203-CIP048_RG4  (H5N1) | Mock Infection","exp_name":"IM007-R","study_title":"IM007: Vietnam/1203-NS1trunc-124/2004 (H5N1) infection in C57 Black 6 Mice: A time course","exp_title":"IM007-R","strain":"Not Applicable","bioset_id":"1252","exp_id":"172","exp_type":"Transcript Quantification","treatment_duration":"24","bioset_name":"IM007_VN1203-NS1trunc_10^3_1d_array","treatment_amount":"1.00E+03 PFU","treatment_type":"Infectious Agent","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005042847700},{"exp_title":"SCL005-P","study_title":"SCL005: SARS Urbani or delta ORF6 Urbani infection in Calu3 cells with variable doses and times post infection.","entity_count":"116","treatment_name":"icSARS dORF6 | Mock Infection","exp_name":"SCL005-P","bioset_criteria":"Criteria of p-value <0 .05","bioset_description":"This is a results matrix that lists proteins  that are differentially expressed in infected cells compared to time matched mock samples.  Calu-3 2B-4 cells were infected with wild type icSARS CoV, icSARS dORF6 or time-matched mock infections.  Time points are 0, 3, 7, 12, 24, 30, 36, 48, 54, 60 and 72hrs post infection.  Differential Expression Criteria: a q-value < .05.","bioset_type":"MS-Proteomics Differential Abundance","organism":"Homo sapiens","study_name":"SCL005","treatment_type":"Infectious Agent","bioset_name":"SCL005_dORF6_12h_proteomics","treatment_amount":"5.00E+00 MOI","exp_type":"Protein Quantification","treatment_duration":"12","exp_id":"159","bioset_id":"1138","strain":"Calu-3 (2B-4) cell","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005043896300},{"bioset_id":"1741","strain":"C57BL/6J","exp_type":"Transcript Quantification","treatment_duration":"144","exp_id":"318","treatment_amount":"100 FFU","bioset_name":"WLN002-R_WNV-E218A_6d","treatment_type":"Infectious Agent","organism":"Mus musculus","study_name":"WLN002","entity_count":"3805","exp_name":"WLN002-R","treatment_name":"West Nile Virus E218A mutant","bioset_criteria":"FC>=1.5 (log2 FC >= 0.58)and q-value <= 0.05","bioset_description":"Differential expression analysis  of popliteal lymph node infected with WNV-E218A for 6 days, compared to time-matched mock-infected samples.","bioset_type":"Microarray Differential Expression","study_title":"WLN002: Infection of C57BL/6J mouse popliteal lymph node with wild type and mutant west nile virus strains","exp_title":"WLN002-R","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005044945000},{"exp_id":"157","exp_type":"Transcript Quantification","treatment_duration":"24","strain":"Not Applicable","bioset_id":"1102","treatment_type":"Infectious Agent","treatment_amount":"1.00E+04 PFU","bioset_name":"IM005_PB2_627E_10^4_1d_array","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_type":"Microarray Differential Expression","bioset_description":"This is a results matrix that contains the differentially-expressed array samples from mice infected with A/Vietnam/1203-CIP048_RG2/2004 (H5N1) or time-matched mock infections.  Time points are 1, 2, 4 and 7 days post infection for mutant virus and mock infections.  Differential Expression Criteria: passes Agilent QC flag and |log2 FC| > 1.5 and q-value < .05.","treatment_name":"VN1203-CIP048_RG2  (H5N1) | Mock Infection","exp_name":"IM005-R","study_name":"IM005","organism":"Mus musculus","exp_title":"IM005-R","study_title":"IM005: Vietnam/1203-PB2-627E/2004 (H5N1) infection in C57 Black 6 Mice: A time course","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005045993500},{"exp_title":"ICL006-R","study_title":"ICL006: A/CA/04/09 (H1N1) infection in Calu3 cell: A time course","entity_count":"360","treatment_name":"CA04 (H1N1) | Mock Infection","exp_name":"ICL006-R","bioset_criteria":"passes Agilent QC flag and |FC| > 1.5 and q-value < .05","bioset_description":"This is a results matrix that lists all DE genes compared to time matched mock samples for Calu-3 cell samples infected with A/CA/04/2009(H1N1) at an MOI of 3.  Time points are 0, 3, 7, 12, 18, 24, 30,36,48 h post infection.  Differential Expression Criteria: passes Agilent QC flag and |FC| > 1.5 and q-value < .05.","bioset_type":"Microarray Differential Expression","organism":"Homo sapiens","study_name":"ICL006","treatment_type":"Infectious Agent","treatment_amount":"3.00E+00 MOI","bioset_name":"ICL006_7hr_H1N1","exp_type":"Transcript Quantification","treatment_duration":"7","exp_id":"150","bioset_id":"1049","strain":"Calu-3 cell","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005047042000},{"treatment_amount":"5.00E+00 MOI","bioset_name":"SCL005_icSARS_3h_proteomics","treatment_type":"Infectious Agent","strain":"Calu-3 (2B-4) cell","bioset_id":"1153","exp_id":"159","exp_type":"Protein Quantification","treatment_duration":"3","study_title":"SCL005: SARS Urbani or delta ORF6 Urbani infection in Calu3 cells with variable doses and times post infection.","exp_title":"SCL005-P","study_name":"SCL005","organism":"Homo sapiens","bioset_type":"MS-Proteomics Differential Abundance","bioset_criteria":"Criteria of p-value <0 .05","bioset_description":"This is a results matrix that lists proteins  that are differentially expressed in infected cells compared to time matched mock samples.  Calu-3 2B-4 cells were infected with wild type icSARS CoV, icSARS dORF6 or time-matched mock infections.  Time points are 0, 3, 7, 12, 24, 30, 36, 48, 54, 60 and 72hrs post infection.  Differential Expression Criteria: a q-value < .05.","entity_count":"123","treatment_name":"icSARS CoV Urbani | Mock Infection","exp_name":"SCL005-P","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005048090600},{"study_title":"DediegoM_AUM_01:  Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates","exp_title":"DediegoM_AUM_01_Mouse_SARS_Expression","study_name":"DediegoM_AUM_01","organism":"Mus musculus","bioset_criteria":"Genes differentially expressed when |log2 FC| > 1, and q-value < .05","bioset_type":"Microarray Differential Expression","bioset_description":"Differential Expression in mouse after infection with SARS-wild type.","treatment_name":"SARS wild type | vehicle control","exp_name":"DediegoM_AUM_01_Mouse_SARS_Expression","entity_count":"3820","bioset_name":"DediegoM_AUM_01_SARS_WT","treatment_amount":"100000 PFU","treatment_type":"Infectious Agent","strain":"Not Applicable","bioset_id":"1451","exp_id":"212","exp_type":"Transcript Quantification","treatment_duration":"48","date_inserted":"2021-12-17T23:37:15.853Z","date_modified":"2021-12-17T23:37:15.853Z","_version_":1809284005049139200}]